Evidence map›Paper›PMID 35313561›Full record

ArticleRespiratory medicine case reports2022

A case of thoracic air leak syndrome with pleural parenchymal fibroelastosis after treatment for hematologic malignancy while awaiting lung transplantation: Imaging and pathological findings of rapid loss in lung volume.

Hajime Kasai, Jiro Terada, Jun Nagata, Keiko Yamamoto, Shunya Shiohira, Atsuko Tomikawa, Nao Tamura, Emiri Yamamoto, Yuzuru Ikehara, Takuji Suzuki

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Respiratory medicine case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Hajime KasaiDepartment of Respirology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Jiro TeradaDepartment of Respirology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Jun NagataDepartment of Respirology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Keiko YamamotoDepartment of Respirology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Shunya ShiohiraDepartment of Medicine, School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Atsuko TomikawaDepartment of Rheumatology and Allergy, Japanese Red Cross Narita Hospital, Narita, 286-0041, Japan.
Nao TamuraAsahi General Hospital, Asahi, 289-2511, Japan.
Emiri YamamotoDepartment of Medicine, School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Yuzuru IkeharaDepartment of Molecular Tumor Pathology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Takuji SuzukiDepartment of Respirology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Chiba University · JPAsahi General Hospital · JPJapanese Red Cross Narita Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the case of a 29-year-old man who underwent umbilical cord blood transplantation for chronic myelogenous leukemia 14 years previously. He was diagnosed with secondary pleuroparenchymal fibroelastosis (sPPFE) following treatment for hematologic malignancies (sPPFE after HM-Tx) 2.5 years ago. On computed tomography, pleural thickening in the upper lobe, lung volume loss, and recurrent bilateral pneumothorax were detected. Although he waited for cadaveric lung transplantation (LTx) for 1.5 years, his respiratory failure worsened, and he died. Pathological autopsy and clinical course indicated sPPFE. After diagnosing sPPFE after HM-Tx, the timing for deciding LTx is critical, especially when pneumothorax recurs.

Indexed as

BMT, bone marrow transplantationBO, bronchiolitis obliteransCT, computed tomographyGVHD, graft-versus-host diseaseHematopoietic stem cell transplantationLONIPC, late-onset noninfectious pulmonary complicationLTx, lung transplantationLung transplantationmMRC, modified Medical Research CouncilPleuroparenchymal fibroelastosisPneumothoraxsPPFE after HM-Tx, secondary pleuroparenchymal fibroelastosis following treatment for hematologic malignanciessPPFE, secondary pleuroparenchymal fibroelastosisTALS, thoracic air-leak syndromeThoracic air-leak syndromeUCBT, umbilical cord blood transplantationVC, vital capacity

Identifiers

PMID35313561
PMCPMC8933706
OpenAlexW4220705764

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.